Clinical Research Directory
Browse clinical research sites, groups, and studies.
Endoscopic Retrograde Cholangiopancreatography
Sponsor: Methodist Health System
Summary
The risk of post-endoscopic retrograde cholangiopancreatography(ERCP) pancreatitis(PEP) is influenced by patient and procedure-related factors. Strategies to decrease PEP(Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis) are of great importance.
Official title: Endoscopic Retrograde Cholangiopancreatography Patient Registry
Key Details
Gender
All
Age Range
15 Years - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2026-02
Completion Date
2028-02
Last Updated
2026-03-24
Healthy Volunteers
No
Conditions
Interventions
Patients undergoing ERCPs at Methodist Dallas Medical Center
The registry will include all patients who meet registry inclusion. Enrollment will terminate once 25 years of data are captured: January 1, 2000 through December 31, 2025.
Locations (1)
Methodist Dallas Medical Center- Clinical Research Institute
Dallas, Texas, United States